MacroGenics, Inc. (MGNX) Financials

MGNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 217.9 million 196.7 million
Dec. 31, 2025 256.8 million 201.3 million
Sept. 30, 2025 270.8 million 203.8 million
June 30, 2025 245.4 million 198.8 million

MGNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -36.2 million 2.6 million
Dec. 31, 2025 42.8 million 2.7 million
Sept. 30, 2025 -30.6 million 3.5 million
June 30, 2025 -47.7 million 3.7 million

MGNX Net Income

No data available :(

MGNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 154.2 million 31.3 million 36.5 million
Dec. 31, 2025 189.9 million 70.0 million 31.6 million
Sept. 30, 2025 146.4 million - 37.0 million
June 30, 2025 176.5 million 70.3 million 37.2 million

MGNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 63.4 million
Dec. 31, 2025 63.2 million
Sept. 30, 2025 63.3 million
June 30, 2025 63.1 million

MGNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 344000 33.3 million 9.7 million -
Dec. 31, 2025 244000 32.3 million 9.2 million -
Sept. 30, 2025 426000 30.9 million 9.9 million -
June 30, 2025 715000 38.9 million 9.3 million -

MGNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 20.8 million 11.2 million
Dec. 31, 2025 41.2 million 11.8 million
Sept. 30, 2025 72.8 million 13.4 million
June 30, 2025 22.2 million 10.8 million

MGNX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MGNX

Price: $3.94

52 week price:
1.19
4.64

Earnings Per Share: -1.11 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 382181

Ebitda: -45.8 million

Market Capitalization: 248.5 million

Links: